Engineered Cell Lines

General description The C2BBe1 cells, a sublcone of Caco-2 cells, correspond to ATCC CRL-2101. The C2BBe1 cells are adenocarcinoma, epithelial cells from a human caucasian male (aged 72 years).

CACO-2 ENGINEERED CONTROL CELL LINE ANNUAL LICENSE

General description The C2BBe1 cells, a sublcone of Caco-2 cells, correspond to ATCC CRL-2101. The C2BBe1 cells are adenocarcinoma, epithelial cells from a human caucasian male (aged 72 years).

CACO-2 ENGINEERED CONTROL CELL LINE EVALUATION LICENSE

Developed to meet the needs of the biotechnology industry, this animal component-free medium is designed for single-cell cloning of recombinant CHO cell lines adapted to serum-free suspension culture. Application This animal component-free medium

General description BM-Series: Biotinylated Monomeric Probes These glycoconjugate probes have an elongated spacer giving them the possibility to bind avidin or streptavidin. The biotin fragment is hydrophobic enough to permit the probes to be

General description Chemical concentration gradients influence normal physiological processes and evolution and progression of many diseases. GradientEZ substrates enable researchers to model gradient-dependent pathological conditions in 3D

General description Chemical concentration gradients influence normal physiological processes and evolution and progression of many diseases. GradientEZ substrates enable researchers to model gradient-dependent pathological conditions in 3D

MCF10A CELLS EEF2K (-/-) are pre-neoplastic mammary epithelial cells from a human adult female with a ZFN knock out modification. This cell line corresponds to ATCC Catalog No.

This cell line corresponds to ATCC Catalog No. CRL-10317.

MCF10A CELLS SMO W535L are pre-neoplastic mammary epithelial cells from a human adult female with a ZFN knock in modification. This cell line corresponds to ATCC Catalog No.

Cell Line Origin A human mesothelioma cell line derived from a malignant mesothelioma. Asbestos exposure Cell Line Description Mero-41 was derived from the pleural effusion from a male patient aged &gt:60 with a history of asbestos exposure